Readers will gain clarity on common pharmaceutical customer data requests, how to structure a five-step sustainability roadmap, and how to mobilize cross-functional teams effectively. The guide also offers insight into avoiding common pitfalls and transitioning from reactive compliance to long-term value creation.
March 4, 2026
What Tier 1 Pharma Suppliers Need to Know
How Can Tier 1 Pharmaceutical Suppliers Meet Growing Sustainability Expectations?
Sustainability transparency is becoming a defining requirement for tier 1 pharmaceutical suppliers as companies like AstraZeneca, Novartis, and GSK more deeply integrate climate action into procurement strategies. Suppliers are increasingly asked to disclose GHG inventories, set science-based targets, and participate in standardized ratings and disclosure platforms.
Key Findings
Leading pharmaceutical companies are standardizing sustainability data requests across their supply chains.
Disclosure of greenhouse gas inventories and science-based targets is quickly becoming a baseline expectation.
Suppliers that take a proactive, structured approach are better positioned to meet customer requirements and reduce business risk.
Moving beyond a compliance mindset can unlock long-term strategic and competitive advantages.
Summary
This G&A Institute resource paper provides a clear framework to help pharmaceutical suppliers understand and respond to evolving sustainability expectations. It outlines practical steps, highlights common challenges, and supports strategic planning as net-zero commitments reshape supply chain requirements.
What You’ll Learn
Contributors
Resource Paper
Download Now
Related Resources
Find what you need. Learn something new.
January 15, 2026 
Build your sustainability strategy.
Chat with our experts to get started on your journey.